Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.M. Foody, J.A. Milberg, K. Robinson, G.L. Pearce, D.W. Jacobsen, D.L. Sprecher.
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.
Arterioscler Thromb Vasc Biol, 20 (2000), pp. 493-499
[2.]
A. Von Eckardstein, H. Schulte, P. Cullen, G. Assmann.
Lipoprotein( a) further increases the risk of coronary events in men with high global cardiovascular risk.
J Am Coll Cardiol, 37 (2001), pp. 434-439
[3.]
B. Cantin, J.P. Despres, B. Lamarche, S. Moorjani, P.J. Lupien, P. Bogaty, et al.
Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study.
Am J Cardiol, 89 (2002), pp. 662-666
[4.]
V. Solfrizzi, F. Panza, A.M. Colacicco, C. Capurso, A. D’Introno, F. Torres, et al.
Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or = 65 years of age (The Italian Longitudinal Study on Aging.
Am J Cardiol, 89 (2002), pp. 825-829
[5.]
K. Berg.
A new serum type system in man: the Lp system.
Acta Pathol Microbiol Scand, 59 (1963), pp. 369-382
[6.]
H.G. Kraft, A. Lingenhel, S. Kochl, F. Hoppichler, F. Kronenberg, A. Abe, et al.
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
Arterioscler Thromb Vasc Biol, 16 (1996), pp. 713-719
[7.]
J. Rubin, F. Paultre, C.H. Tuck, S. Holleran, R.G. Reed, T.A. Pearson, et al.
Apolipoprotein[a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.
J Lipid Res, 43 (2002), pp. 234-244
[8.]
S. Martín, J. Pedro-Botet, J. Joven, J.M. Simó, M.G. Ladona, M. Pavesi, et al.
Heterozygous apolipoprotein(a) status and protein expression as a risk factor for premature coronary heart disease.
J Lab Clin Med, 139 (2002), pp. 181-187
[9.]
A.M. Scanu.
Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.
Curr Atheroscler Rep, 5 (2003), pp. 106-113
[10.]
W.Y. Craig, T.B. Ledue.
Lipoprotein(a) and the acute phase response.
Clin Chim Acta, 210 (1992), pp. 231-232
[11.]
D.J. Grainger, P.R. Kemp, A.C. Liu, R.M. Lawn, J.C. Metcalfe.
Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein( a) mice.
Nature, 370 (1994), pp. 460-462
[12.]
S. Pillarisetti, L. Paka, J.C. Obunike, L. Berglund, I.J. Goldberg.
Subendothelial retention of lipoprotein(a): evidence that reduced heparin sulfate promotes lipoprotein binding to subendothelial matrix.
J Clin Invest, 100 (1997), pp. 867-874
[13.]
M. Poon, X. Zhang, K.G. Dunsky, M.B. Taubman, P.C. Harpel.
Apolipoprotein( a) induces monocyte chemotactic activity in human vascular endothelial cells.
Circulation, 96 (1997), pp. 2514-2519
[14.]
S.M. Marcovina, M.L. Koschinsky.
Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
Curr Opin Lipidol, 14 (2003), pp. 361-366
[15.]
J. Loscalzo.
Lipoprotein(a): a unique risk factor for atherothrombotic disease.
Arteriosclerosis, 10 (1990), pp. 672-679
[16.]
E.G. Levin, L.A. Miles, G.M. Fless, A.M. Scanu, P. Baynham, L.K. Curtiss, et al.
Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.
Arterioscler Thromb, 14 (1994), pp. 438-442
[17.]
X.N. Li, H.E. Grenett, R.L. Benza, S. Demissie, S.L. Brown, E.M. Tabengwa, et al.
Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 3215-3223
[18.]
D.G. Hackam, S.S. Anand.
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.
Jama, 290 (2003), pp. 932-940
[19.]
J. Danesh, R. Collins, R. Peto.
Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies.
Circulation, 102 (2000), pp. 1082-1085
[20.]
L.A. Carlson, A. Hamsten, A. Asplund.
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid.
J Intern Med, 226 (1989), pp. 271-276
[21.]
S.M. Marcovina, J.J. Albers, A.M. Scanu, H. Kennedy, F. Giaculli, K. Berg, et al.
Use of a reference material proposed by the Internacional Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein (a).
Clin Chem, 46 (2000), pp. 1956-1967
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.